Cargando…
Comorbidities and COVID-19
Autor principal: | Yaddanapudi, Lakshmi Narayana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573989/ https://www.ncbi.nlm.nih.gov/pubmed/33100641 http://dx.doi.org/10.4103/joacp.JOACP_305_20 |
Ejemplares similares
-
The Impact of Frailty and Comorbidities on Heart Failure Outcomes
por: Salmon, Thomas, et al.
Publicado: (2022) -
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
por: Rosenkranz, Stephan, et al.
Publicado: (2021) -
COVID-19, COMORBIDITIES, AND OUTCOMES IN SEVERE ILLNESS
por: HOOSHMAND, KEVIN, et al.
Publicado: (2021) -
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
por: Lindner, Lisa, et al.
Publicado: (2020) -
Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome
por: Traianos, Emmanuella Young, et al.
Publicado: (2020)